The federal government’s intention to pass a Canada Pharmacare Act in 2023 is an opportunity to assess how private health insurance plans can offer the most benefit for Canadians. At its most recent policy summit, Innovative Medicines Canada brought together key stakeholders in Canada’s private health insurance landscape to explore what’s next for private drug benefits and how collaboration and innovation are essential for their future.
More than 97 per cent of Canadians — or roughly 37 million people — are eligible for some form of prescription drug coverage through public or private plans, according to the Conference Board of Canada. More than 24 million Canadians are enrolled in a private plan and nearly 25 million Canadians are eligible for public coverage….
